期刊文献+

抗鸡补体C3抗体的制备及其应用 被引量:1

Preparation and application of anti-chicken complement C3 antibody
下载PDF
导出
摘要 选取鸡源补体C3α链的21个氨基酸残基序列,人工合成模拟C3分子的21肽[741-761],与牛血清白蛋白载体偶联结合后,制成人工合成抗原复合物。将此人工合成抗原加弗氏佐剂制成油乳剂疫苗,免疫注射家兔制备成抗21肽抗体。从抗血清中提纯IgG,用以检测不同动物血清中C3含量。结果表明,人工合成的C3分子的21肽复合抗原具有很强的免疫原性,制成的抗血清的IgG效价达29,且能与不同动物血液的C3分子发生特异性结合;用该IgG对鸡、猪、山羊、牛和豚鼠体内的C3进行了检测,其含量分别为(0.34±0.005)、(1.47±0.008)、(1.70±0.005)、(1.78±0.007)、(4.18±0.008)g/L,发现鸡体内的C3含量明显低于其他几种动物,差异极显著(P<0.01),这可能是鸡体对细菌性疫苗免疫效果不佳的主要原因。 The 21 amino acid of chicken complement C3^741-761 was selected out of its a chain to synthesize the 21 peptide. The 21 peptide was coupled with the cattle serum albumin to fabricate the antigen compound. Which mixed with the Frund adjuvant and emulsificated to immunise the rabbit to get the anti-21 peptide antibody. The IgG was purified to assay the C3 content in the serum of different animals. It showed that the antigenicity of the synthesized antigen is very strong, The efficacy of purified IgG from the anti-serum is 2^9. The antibody can bind tothe complement C3 of different animal. The C3 content of different animal serum assayed by the antibody are : chicken (0.34±0.005)g/L, pig(1.47±0.008)g/L, goat(1.70±0.005) g/L, cattle(1.78±0.007) g/L, guineapig(4.18±0.008)g/L. It showed that the C3 content of the chicken is extremely lower than the other animal (P〈 0.01). This may account for the less effects of the bacterial vaccines in chicken.
出处 《中国兽医学报》 CAS CSCD 北大核心 2007年第3期359-362,共4页 Chinese Journal of Veterinary Science
基金 山东省财政支持项目(SDGP2004-54-O)
关键词 C3 21肽 半抗原载体 抗体 C3 21 peptide hapten carrier antibody
  • 相关文献

参考文献8

  • 1赵修竹.补体学[M].湖南长沙:湖北科学技术出版社,1998.48-49.
  • 2林雪颜 张玲.现代细胞与分子免疫学[M].北京:科学出版社,1999.297-322.
  • 3Manolis Mavroidis,Sunyer J O,Lambris J D.Isolation Primary Struture and Evolution of the Third Component of Chicken Complement and Evidence for a New Member of the α2-Macroglobulin Family[J].J Immunol,1995,154(5):2164-2174.
  • 4孙蕙兰,牛钟相,朱瑞良.抗赭曲霉毒素A抗体的研制与鉴定[J].畜牧兽医学报,1991,22(3):235-237. 被引量:9
  • 5朱立平,陈学清.免疫学常用试验方法[M].北京:人民军医出版社,2000.
  • 6汪家政 范明.蛋白质技术手册[M].北京:科学出版社,2002.77-97.
  • 7陈宏,温海,徐红,廖万清.两性霉素B和5-氟胞嘧啶的体外联合药敏试验[J].第二军医大学学报,2003,24(4):453-454. 被引量:10
  • 8Becherer J D,Aisenz J,Esparza I,et al.A segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates binding of CR1,factor H.and factor B[J].Biochemistry,1991,31:1787.

二级参考文献8

  • 1孙蕙兰,山东农业大学学报,1989年,20卷,1期,1页
  • 2有祥熊,1984年
  • 3Chang F C,1976年
  • 4Chu F S,Appl and Envi Microbiol,1976年
  • 5Chu F S,Crit Rev Toxicol,1974年,2卷,499页
  • 6Chu F S,Archives of Biochemistry and Biophysics,1971年
  • 7Marchetti O,Moreillon P,Glauser MP,et al.Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans[].Antimicrobial Agents and Chemotherapy.2000
  • 8Rodero L,Cordoba S,Cahn P,et al.In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy[].Journal of Antimicrobial Chemotherapy.2000

共引文献187

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部